cisplatin,vedolizumab,pembrolizumab,enfortumab,carboplatin,gemcitabine
seagen,astellas,merck,takeda
['cisplatin', 'enfortumab', 'pembro', 'urothelial', 'vedo', ' vedo']
enfortumab vedotin (ev) with or without pembrolizumab (p) in patients (pts) who are cisplatin-ineligible with previously untreated locally advanced or metastatic urothelial cancer (la/muc): additional 3-month follow-up on cohort k data. #asco23 #asco2023 #medtwitter #news 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News